Krystal Biotech (KRYS) Other Non-Current Liabilities (2018 - 2026)
Krystal Biotech (KRYS) reported Other Non-Current Liabilities of $5.1 million for Q1 2026, up 155.0% on a YoY basis from $2.0 million in Q1 2025, and up 36.95% sequentially from $3.7 million in Q4 2025.
Krystal Biotech (KRYS) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 4 years of Other Non-Current Liabilities data on file, last reported at $5.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 155.0% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (up 155.0% YoY), and the FY2025 full-year result was $3.7 million, up 162.44% from the prior year.
- Other Non-Current Liabilities advanced to $5.1 million in Q1 2026, from $3.7 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $5.1 million in Q1 2026 to a low of $588000.0 in Q2 2024.
- A 3-year average of $2.4 million and a median of $2.4 million in 2025 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities soared 373.98% in 2025 and soared 155.0% in 2026, its largest moves.
- Tracing KRYS's Other Non-Current Liabilities over 3 years: stood at $1.4 million in 2024, then soared by 162.44% to $3.7 million in 2025, then surged by 36.95% to $5.1 million in 2026.
- Business Quant data shows KRYS's Other Non-Current Liabilities at $5.1 million in Q1 2026, $3.7 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 3.72 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 761,000.00 |
| Jun 30, 2024 | 588,000.00 |
| Dec 31, 2018 | 294,000.00 |
| Sep 30, 2018 | 245,000.00 |